Diphenylsulfane

Diphenylsulfane

SCHEMBL9810992

[SnH2].c1ccc(Sc2ccccc2)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.56
MAPT P10636 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
MGLL Q99685 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MAOA P21397 3/20 0.55
MAOB P27338 3/20 0.55
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 3/20 0.47
HTR2C P28335 1/20 0.44
HTR6 P50406 1/20 0.44
SLC6A4 P31645 1/20 0.44
NR1H2 P55055 1/20 0.42
DDAH1 O94760 1/20 0.42
NOS1 P29475 1/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
CHRNA7 P36544 1/20 0.41
HTT P42858 1/20 0.41
TUBB4A P04350 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylsulfane SCHEMBL27714827 0.96 HPGD (0.60) HPGDMAPTSMN1; SMN2MGLLHSD17B10
Diphenylsulfane SCHEMBL452 0.96 HPGD (0.60) HPGDMAPTSMN1; SMN2MGLLHSD17B10
Diphenylsulfane SCHEMBL7109540 0.96 HPGD (0.60) HPGDMAPTSMN1; SMN2MGLLHSD17B10
Diphenylsulfane SCHEMBL27611905 0.96 HPGD (0.60) HPGDMAPTSMN1; SMN2MGLLHSD17B10
Diphenylsulfane SCHEMBL28332331 0.96 HPGD (0.60) HPGDMAPTSMN1; SMN2MGLLHSD17B10
SCHEMBL23277364 0.92 MAOA (0.62) HPGDMAPTSMN1; SMN2MGLLHSD17B10
Diphenylsulfane SCHEMBL5417674 0.92 HPGD (0.56) HPGDMAPTSMN1; SMN2MGLLHSD17B10
SCHEMBL795030 0.92 MAOA (0.62) HPGDMAPTSMN1; SMN2MGLLHSD17B10
Diphenylsulfane SCHEMBL6554424 0.92 HPGD (0.56) HPGDMAPTSMN1; SMN2MGLLHSD17B10
SCHEMBL3891151 0.92 MAOA (0.62) HPGDMAPTSMN1; SMN2MGLLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118047825-A Preparation method of desacetyl erigeron glycoside 威智医药股份有限公司 2024-05-17 CN claimed
CN-113999276-B Purification method and preparation method of desacetyl erigeron glycoside intermediate 威智医药股份有限公司 2023-08-15 CN claimed
CN-113045736-B Poly (glycolic acid) for containers and films having reduced gas permeability 美国达克有限责任公司 2024-08-02 CN disclosed
CN-112584796-B Cylindrical body for implant 东丽株式会社 2024-05-28 CN disclosed
CN-113999276-B Purification method and preparation method of desacetyl erigeron glycoside intermediate 威智医药股份有限公司 2023-08-15 CN disclosed
CN-111868143-B Biodegradable block copolymer 东丽株式会社 2022-10-04 CN disclosed
EP-0246414-B1 METHOD OF SUPPRESSING SODIUM POISONING OF CRACKING CATALYSTS DURING FLUID CATALYTIC CRACKING CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1991-06-26 EP disclosed
US-4889617-A PASSIVATION WITH TIN OR TIN COMPOUNDS CHEVRON RESEARCH COMPANY (US) 1989-12-26 US disclosed
EP-0246414-A1 Method of suppressing sodium poisoning of cracking catalysts during fluid catalytic cracking CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1987-11-25 EP disclosed